DMR News

Advancing Digital Conversations

Aletheia Capital Endeavours Launches RepIntel, a Campaign-Grade Platform to Accelerate Global Access to Therapies

ByEthan Lin

Oct 17, 2025

Aletheia Capital Endeavours (ACE) today announced the launch of RepIntel, a precision field-intelligence platform designed to close one of healthcare’s most persistent gaps: the failure of lifesaving therapies to reach the patients they were created for. 

The company was founded by Gavin Perri, the New York impresario and Executive Chairman of Aletheia Capital Endeavours, and Filomena Di Luise, Senior Executive Manager at a Fortune 100 technology firm, who will serve as President and Chief Operating Officer for RepIntel. Di Luise brings enterprise-scale infrastructure expertise to the venture’s leadership team. 

Drawing on frameworks that redefined political mobilization, RepIntel translates those same principles of precision targeting, coordinated field orchestration, and real-time intelligence into the final mile of healthcare delivery. 

“Every year, scientific breakthroughs transform what medicine can do. Yet millions still go without the treatments that could change or save their lives,” said Gavin Perri, Executive Chairman of Aletheia Capital Endeavours. “RepIntel is designed to solve that systemic failure. By transforming field operations into an adaptive intelligence network, we’re building the connective tissue that allows innovation to translate into real-world impact.” 

RepIntel unites vast healthcare datasets with ground-level decision-making, enabling pharmaceutical teams to identify unmet needs, prioritize underserved populations, and orchestrate outreach with surgical precision. Its first deployments target highly regulated markets, where the speed, accuracy, and equity of distribution directly determine patient outcomes. 

The launch marks ACE’s first flagship technology venture and reflects a broader thesis: that the most resilient and equitable healthcare systems will be those that harness distributed intelligence, empowering those closest to patients to guide the flow of treatments and resources in real time. In doing so, RepIntel establishes the operational layer needed to ensure that scientific progress becomes societal progress.

Ethan Lin

One of the founding members of DMR, Ethan, expertly juggles his dual roles as the chief editor and the tech guru. Since the inception of the site, he has been the driving force behind its technological advancement while ensuring editorial excellence. When he finally steps away from his trusty laptop, he spend his time on the badminton court polishing his not-so-impressive shuttlecock game.

Leave a Reply

Your email address will not be published. Required fields are marked *